ホーム › COPD › アラバマ州 › Birmingham
Birmingham、ALにおけるCOPDの臨床試験
Birminghamとその周辺地域（約30マイル以内）の拠点で、COPDに関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
被験者募集中第3相
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
被験者募集中第2相
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
被験者募集中第4相
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
被験者募集中第2相
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
被験者募集中第2相
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
被験者募集中第1相
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
被験者募集中第2/3相
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
被験者募集中第3相
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
被験者募集中観察研究
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
被験者募集中第3相
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
被験者募集中
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
被験者募集中観察研究健康なボランティア歓迎
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
被験者募集中
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
被験者募集中
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
被験者募集中観察研究
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
被験者募集中第4相
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
被験者募集中
- UAB School of Medicine/Lung Health Center, Birmingham
他の都市におけるCOPDの試験
- Philadelphia, PA23件の研究
- Miami, FL18件の研究
- Boston, MA17件の研究
- Houston, TX15件の研究
- Orlando, FL15件の研究
- Baltimore, MD14件の研究
- Chicago, IL14件の研究
- Pittsburgh, PA12件の研究
- Dallas, TX12件の研究
- New York City, NY11件の研究
- Ann Arbor, MI10件の研究
- Detroit, MI9件の研究
Birminghamにおける他の研究
- がん（全種類）30件の研究
- 乳がん24件の研究
- 卵巣がん23件の研究
- 肥満症23件の研究
- 非小細胞肺癌22件の研究
- 急性骨髄性白血病21件の研究
- 多発性骨髄腫18件の研究
- 心血管疾患17件の研究
- 2型糖尿病16件の研究
- 過体重16件の研究
- 嚢胞性線維症16件の研究
- 子宮内膜がん15件の研究
ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。